Importantly and different to our study with EML4-ALK positive NSCLC cells, combining Crizotinib with autophagy inhibition to treat ALCL cells did not result in increased cell death, indicating autophagy-associated cell death36. Here, ALK is linked to anaplastic large cell lymphoma.